These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 14359545)

  • 1. Study of disorders of renal elimination of sodium in alcoholic cirrhosis with ascites.
    CACHERA R
    Union Med Can; 1955 Jan; 84(1):8-24. PubMed ID: 14359545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of renal sodium elimination in alcoholic cirrhosis with ascites].
    CACHERA R
    Brux Med; 1954 Nov; 34(45):2203-17. PubMed ID: 13209210
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of renal elimination of sodium in alcoholic cirrhosis with ascites].
    CACHERA R; DARNIS F; LUBETZKI J
    Sem Hop; 1953 Nov; 29(70):3613-23. PubMed ID: 13122079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renal elimination of sodium in alcoholic liver cirrhosis with ascites].
    CACHERA R; DARNIS F; LUBETZKY J
    Rev Invest Clin; 1955; 7(1):9-28. PubMed ID: 14395815
    [No Abstract]   [Full Text] [Related]  

  • 5. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
    Therapondos G; Hol L; Benjaminov F; Wong F
    Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.
    Esteva-Font C; Baccaro ME; Fernández-Llama P; Sans L; Guevara M; Ars E; Jiménez W; Arroyo V; Ballarín JA; Ginès P
    Hepatology; 2006 Dec; 44(6):1555-63. PubMed ID: 17133493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
    Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
    J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
    Ahloulay M; Bankir L; Lugnier C; Le Bec A; Poirel O; Moreau R; Lebrec D
    Liver Int; 2005 Apr; 25(2):403-9. PubMed ID: 15780066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract]   [Full Text] [Related]  

  • 12. Alcoholic cirrhosis-associated hepatorenal syndrome treated with vasoactive agents.
    Esrailian E; Runyon BA
    Nat Clin Pract Nephrol; 2006 Mar; 2(3):169-72. PubMed ID: 16932415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
    Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
    Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urine electrolytes: use and pitfalls to avoid].
    Fumeaux Z; Stoermann Chopard C
    Rev Med Suisse; 2005 Feb; 1(8):557-8, 560-1. PubMed ID: 15794305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis.
    Domenicali M; Caraceni P; Principe A; Pertosa AM; Ros J; Chieco P; Trevisani F; Jiménez W; Bernardi M
    J Hepatol; 2005 Jul; 43(1):92-7. PubMed ID: 15893844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of contrast media on renal function in patients with cirrhosis: a prospective study.
    Guevara M; Fernández-Esparrach G; Alessandria C; Torre A; Terra C; Montañà X; Piera C; Alvarez ML; Jiménez W; Ginès P; Arroyo V
    Hepatology; 2004 Sep; 40(3):646-51. PubMed ID: 15349903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia in cirrhosis: Results of a patient population survey.
    Angeli P; Wong F; Watson H; Ginès P;
    Hepatology; 2006 Dec; 44(6):1535-42. PubMed ID: 17133458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.